New research by @UF neuroscientists shows FDA-approved form of electric fields therapy holds promise to potentially stimulate immune response against glioblastoma recurrence. Findings reported in @jclinicalinvest online. @UFNeurosurgery
https://t.co/ggJkjhYhnw